Stephan Schoonvelde

Stephan Schoonvelde serves as a Researcher in the Department of Cardiology at Erasmus MC, Rotterdam, specializing in inherited cardiac conditions with emphasis on hypertrophic cardiomyopathy pathogenesis and clinical management. His work bridges genetic analysis with patient-centered outcomes assessment across multiple collaborative studies.

Research priorities include:

• Hypertrophic Cardiomyopathy mechanisms
• Genotype-phenotype discordance in cardiac genetics
• Cardiovascular risk factor modulation
• Disease burden quantification
• Sudden cardiac death prediction
• Patient quality-of-life metrics

Current investigations focus on genotype-negative hypertrophic cardiomyopathy cases, utilizing accelerometry for objective activity monitoring and evaluating metabolic therapies like trimetazidine in pre-clinical disease stages. His ENERGY trial contribution demonstrates methodological rigor in assessing myocardial efficiency through randomized controlled designs while exploring genotype-positive phenotype-negative populations for optimized family screening protocols.

No scientific awards were documented in available profile materials.

Academic advising activities and research funding details remain unspecified in source documentation, with no laboratory or team affiliations explicitly identified beyond Erasmus MC Cardiology department collaborations.